About this trial
Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).
Eligibility criteria
Qualifiers
known multiple myeloma
verified lesion(s) between Th6-L5
4 or less fractures
relevant pain in 3 months or less
Disqualifiers
presence of neurologic deficit
psychological or psychiatric disorder hat is expected to interfere with compliance
Trial design
Treatments tested in this trial
- Vertebroplasty